finance

23andMe CEO Anne Wojcicki Plans to Take Company Private




The intentions, revealed in a public filing, come after the once-hot company’s share price closed at a new low and its enterprise value fell below zero.



READ SOURCE

Read More   Y-mAbs expands board with oncology expert

This website uses cookies. By continuing to use this site, you accept our use of cookies.